Nazal (Sato Pharmaceutical Co., Ltd.)
Welcome to the PulseAid listing for the Nazal drug offered from Sato Pharmaceutical Co., Ltd.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sato Pharmaceutical Co., Ltd. |
| NON-PROPRIETARY NAME: | Naphazoline hydrochloride |
| SUBSTANCE NAME: | NAPHAZOLINE HYDROCHLORIDE |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | NASAL |
| DOSAGE FORM: | LIQUID |
| MARKETING CATEGORY NAME: | OTC MONOGRAPH NOT FINAL |
| START MARKETING DATE: | 1990-06-11 |
| END MARKETING DATE: | 0000-00-00 |
Nazal HUMAN OTC DRUG Details:
| Item Description | Nazal from Sato Pharmaceutical Co., Ltd. |
| LABELER NAME: | Sato Pharmaceutical Co., Ltd. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/100mL) |
| START MARKETING DATE: | 1990-06-11 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 49873-057_7750c714-3e28-4951-a0ea-b8521d6ec2a0 |
| PRODUCT NDC: | 49873-057 |
| APPLICATION NUMBER: | part341 |
Other NAPHAZOLINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
